Regulators in Oregon have awarded a license for the first psilocybin service center in the nation to EPIC Healing Eugene. The facility will allow individuals in need to receive the psychedelic in a facilitated and supervised environment. With this move, the state has now officially approved a license for each of the four business categories established by the psilocybin law.
In a press release, Oregon Psilocybin Services Section Manager Angie Allbee stated that this was a historic moment with psilocybin services becoming more available in the state.
The Oregon Health Authority has, in the last few weeks, approved various permits and licenses. In April, the authority approved a list of state-licensed facilitators that would administer the psychedelic to adults at the regulated centers. This is in addition to giving the go ahead on a testing lab for psilocybin.
In March, regulators also approved a state-issued license for a manufacturer of psilocybin. In addition, the authority has also granted 84 psilocybin permits to employees thus far. It is expected that more worker permits and licenses will be issued in the near future.
Despite these positive strides, implementing the psilocybin measure in the state has experienced some issues. For instance, the Synthesis Institute, which heavily invested in the creation of a facilitators’ training program to enable the administration of psilocybin at the approved facilities, recently announced that it was bankrupt. Local access is another hiccup, as more than 100 cities in Oregon have enacted bans or moratoriums preventing facilities from being set up in their jurisdictions.
In other news, the state’s Psilocybin Advisory Board is promoting studies into the medical potential of psilocybin. In 2021, members released a report on the psychedelic that explored the science, after which the board approved a team of researchers to develop a detailed review of the history, science and culture psilocybin.
Meanwhile, legislators in Colorado forwarded legislation to the governor last week. The new measure would establish a regulatory framework for legal psychedelics, as stipulated under a voter-approved initiative that legalized an extensive range of psychedelic substances and offered controlled access to psilocybin. This comes at a time when more states are reforming laws governing psychedelics.
In April, a GOP legislator in North Carolina and a bipartisan group of cosponsors filed a measure to establish a million-dollar grant program to support studies into the therapeutic potential of MDMA and psilocybin and to set up a research advisory board for breakthrough therapies to oversee the effort.
All these efforts to reform the policies surrounding psychedelics come amid a flurry of R&D programs by enterprises such as Seelos Therapeutics Inc. (NASDAQ: SEEL), which are yielding promising results regarding the medicinal potential of these substances.
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
